Analyst firms · BofA Securities · GMED
BofA Securities GMED price target and rating history
Globus Medical Inc. (GMED) · Health Care
BofA Securities rates Globus Medical Inc. (GMED) Buy with a $91 price target, as of its latest action on Nov 7, 2025. It has published 4 rating actions on GMED since December 2021, including 3 upgrades and 1 downgrade. Across 4 firms with a GMED price target in the last 12 months, the median target is $96.
- Current rating
- Buy
- Price target
- $91
- Median target, all firms
- $96
- Actions on GMED
- 4
BofA Securities price target on GMED
Every BofA Securities rating on GMED
- Nov 7, 2025
- Jan 10, 2025
- Feb 13, 2023
- Dec 13, 2021
How other firms rate GMED
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BMO Capital Markets | Market Perform | $78 | Nov 6, 2026 |
| UBS | Neutral | $82 | Jul 28, 2026 |
| Needham | Buy | $112 | Jan 30, 2026 |
| TD Cowen | Buy | $110 | Jan 27, 2026 |
Questions about BofA Securities and GMED
- What is BofA Securities's price target for GMED?
- BofA Securities's latest stated price target for Globus Medical Inc. (GMED) is $91, from its action on Nov 7, 2025.
- What is BofA Securities's rating on GMED?
- BofA Securities rates GMED Buy, a bullish rating, as of Nov 7, 2025.
- When did BofA Securities last change its view on GMED?
- On Nov 7, 2025, BofA Securities upgrades to Buy from Neutral, price target $91.
- How does BofA Securities's GMED target compare with other analysts?
- Across 4 firms with a GMED price target in the last 12 months, the median target is $96.
More GMED rating histories
All BofA Securities ratingsGMED news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.